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Some major themes over the past year in clinical research of osteoarthritis (OA) include obesity, muscle
strength, pain mechanisms, novel disease modifying drugs, and risk factors for poor outcomes of joint
replacement surgery. A systematic literature search was performed using PubMed from January 2012 to
December 2012. The articles selected for this review represent topics the authors thought best highlight
recent clinical OA research.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) continues to be the most common form of
arthritis in the western world with a signiﬁcant impact on patient
quality of life, morbidity and healthcare costs. OA is not a single
disease entity, but a common end stage phenotype of many
different disease processes which involves all joint tissues. The
identiﬁcation of different pathogenic mechanisms and disease
phenotypes is essential to allow clinicians direct suitable therapy
towards appropriate patients and to facilitate future research of
disease modifying drugs in this important musculoskeletal disease.
The publications from the past year include interesting work
exploring a variety of pathogenic mechanisms leading to OA and
the resulting disease phenotypes.
This manuscript will explore recent clinical developments in the
ﬁeld of OA relating to epidemiology, advances in pain mechanism
understanding, novel disease modifying drugs and risk factors for
determining poor outcomes after replacement surgery.Methods
The primary literary research was performed using PubMed
(http://www.ncbi.nlm.gov/pubmed), reviewing articles published
from January 2012 to December 2012. Search terms included OA,
clinical epidemiology, and treatment. This was complimented by aN.K. Arden, Botnar Research
gy and Musculoskeletal Sci-
. Arden).
s Research Society International. Phand search of Rheumatology & Osteoarthritis journals. Following
the Osteoarthritis Research Society International (OARSI) meeting
in Philadelphia in April 2013, selected articles from January 2013 to
July 2013 were also added.
Titles of all articles were reviewed for relevant subjects. Topics
covered by other reviews in this publication including genomics,
imaging, rehabilitation outcomes, biomarkers and biology were
excluded. The articles included in this review were selected to




A common theme of OA research in the past yearwas the effect of
obesity and its associated metabolic risk factors on OA prevalence
and incidence. The arcOGENconsortiumconductedoneof the largest
genome wide association studies on OA. They found several new
single-nucleotide polymorphisms (SNPs) linked to OA, in addition to
a near signiﬁcant association of the fat-mass and obesity-associated
(FTO) gene, which is involved in the regulation of body-weight1.
Yoshimura et al. explored the relationship between metabolic syn-
drome and knee OA in a large-scale population-based cohort in
Japan2. They found that the risk of incident knee OA increased along
with the number of metabolic syndrome factors present, with odds
of 2.3 for having two factors up to 9.8 for three or more factors. The
strongest associations were seen with obesity and hypertension.
Karnoven-Gutierez et al. looked at cardiometabolic dysfunction,
obesity and knee OA in a population-based study and found that
leptin levels and insulin resistancewere higher in subjectswith kneeublished by Elsevier Ltd. All rights reserved.
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results suggesting different mechanisms, with increased insulin
resistance being more signiﬁcant for men and leptin levels more
important for obesewomen. Lee et al. investigated the relationship of
different types of fat mass and knee OA in a Korean population,
subdividing subjects into normal, sarcopenic non-obesity, non-sar-
copenic obesity, and sarcopenic obesity groups4. Sarcopenic obesity
demonstrated the strongest association with radiographic OA (odds
ratio (OR) 3.51) followed by non-sarcopenic obesity (OR 2.38), with
no signiﬁcant association with sarcopenic non-obesity (OR 0.94)
compared to normal subjects. These results were independent of
waist circumference. Hoeven et al. found that measures of arthero-
sclerosis were independently associated with prevalence of OA5. In
women, carotid intima media thickness (IMT) showed an indepen-
dent association with the prevalence of knee OA and carotid plaque
with distal interphalangeal OA and metacarpophalangeal OA. An
independent association for IMT with progression of meta-
carpophalangeal OA was also found in women. Gudbergsen et al.
lookedat the effectof a 16-weekweight-loss regimeon symptomatic
relief in an elderly and obese group of patients6. They found an
improvement of 14% on the knee injury and osteoarthritis outcome
score (KOOS) score and 64% response rate on the OARSI/outcome
measures in rheumatology (OMERACT) criteria independent of
structural damage at baseline, muscle strength and alignment.
Muscle strength
Reduced muscle strength is a possible mechanism for causing
symptomatic OA. Quadricep weakness, speciﬁcally, has been asso-
ciated with functional disability and pain independently of radio-
graphic disease, which is thought to arise from the failure of
stabilising the joint during activity and greater loading of the joint.
Research over the past year has further investigated this relation-
ship by looking at other muscles and forces, which may further
explain this relationship. In a small study of subjects with unilateral
knee pain, Sattler et al. found that painful knees had 5.2%
(P < 0.001) lower extensor thigh muscle cross-sectional area
(MCSA) than non-painful contralateral knees of the same radio-
graphic severity, in addition to a 7.8% (P < 0.01) lower maximal
extensor quadriceps force7. Other thigh muscles did not show these
types of differences between painful and painless knees. Conroy
et al. evaluated muscle quality in a large population-based cohort
(n ¼ 858) with and without radiographic osteoarthritis (ROA) and
pain by measuring muscle area on computerized tomography (CT)
and isokinetically measuring quadriceps strength8. Researchers
found that subjects with ROA had poorer muscle quality as indi-
cated by lower speciﬁc torque (peak strength divided by total thigh
muscle area) (P < 0.001) independent of pain status and body mass
index (BMI). This same difference was not found for quadriceps
speciﬁc torque (peak strength divided by quadriceps area). Wang
et al. examined the longitudinal relationship between the change in
the cross-sectional area (CSA) of the vastus medialis muscle and
symptomatic OA and future risk of knee replacement9. An increase
of the vastusmedialis CSA over 2 years was associatedwith reduced
Western Ontario and McMaster Universities Osteoarthritis Index
(WOMAC) knee pain (r ¼ 0.24, P ¼ 0.007), and a reduced risk of
knee replacement over 4 years (OR 0.61 [95% conﬁdence interval
(CI) 0.40e0.94]). These studies are promising indications of a risk
factor that is relatively easy to inﬂuence on a standard care pathway
involving physiotherapy for relief of symptoms.
Morphology
A rapidly expanding area of research is in the morphological
variation of joint shape and how it is related to disease incidenceand progression. Barr et al. used active shape modelling to analyse
whether proximal femoral morphology could predict the need for a
future hip replacement independent of radiographic severity10.
They found seven different modes which explained the morpho-
logical variation of the proximal femur in their symptomatic pa-
tients, one of which (mode 2) was signiﬁcantly protective against a
future hip replacement after adjustment for ROA, clinical variables
and othermorphological factors (OR 0.17 [95% CI 0.04e0.71]). These
results indicate the importance of assessing joint morphology in
addition to other factors when evaluating risk of OA and joint
replacement. Wise et al. looked at the variation in compartmental
disease involvement between Whites and African Americans and
men andwomen in a large population-based cohort11. They found a
higher prevalence of lateral joint space narrowing in women
compared to men (OR 1.9 [95% CI 1.5e2.4]) and in African Ameri-
cans compared to Whites (OR 2.4 [95% CI 1.7e3.3]). After adjusting
for alignment, this difference was non-signiﬁcant between men
and women, but remained signiﬁcant between African Americans
and Whites. This indicates the role of valgus alignment for
explaining the variation of compartmental involvement between
genders.
Erosive hand OA
It is estimated that 2.8% of the general population have erosive
OA, rising to 15.5% in those with symptomatic hand OA over the age
of 55 and to 50% in those with hand OA in rheumatology clinics12.
Wittoek et al. imaged the hands of 270 consecutive patients with
hand OA (167 with erosive hand OA (EOA)) from three clinics in
Belgium and compared them with 79 patients with controlled in-
ﬂammatory arthritis (IA)13. Patients with EOA used more pain
relieving drugs than non-EOA or controlled IA. Self-reported pain
and function was signiﬁcantly worse in EOA than non-EOA and IA.
Kortekaas et al. imaged thehandsof a small groupofpatientswho
fulﬁlled the American College of Rheumatology (ACR) criteria for
erosive hand OA 12. 51% of patients had at least one erosive joint.
Power Doppler signal and effusion scores were higher in the erosive
group, including joints, whichwere not currently erosive suggesting
an early diffuse systemic inﬂammatory process. Addimanda et al.
found similar increased severity in an EOA group, where erosive
hand OA patients (with at least two erosions) showed a higher
percentage of nodes and more severe radiographic OA14. Marginal
erosions were present in 100% of EOA patients and 80% of the non-
EOA patients.
Pain
The mechanisms for OA related pain are complex. Increasingly,
pain research has focused on identifying possible subsets of pa-
tients with centralised rather than localised pain. Dowsey et al.
found that 30% of patients had unsatisfactory pain scores and 50%
suboptimal functional scores after their knee replacement sur-
gery15. However, they found that patients with worse pre-operative
radiographic grades had better post-operative pain and function
scores. These results are consistent with previous research and
suggest that severe pain in patients withmild radiographic changes
may be due to central sensitisation rather than localised pain16.
Wylde et al. assessed knee OA patients for somatosensory abnor-
malities using quantitative sensory testing (QST) against a control
group17. They found that 71% of OA patients had at least one ab-
normality, including higher light touch threshold (P< 0.001), lower
pain pressure threshold (PPT) (P < 0.001) and higher detection
thresholds for warm and cold stimuli (P < 0.05). Graven-Nielson
et al. also explored the role of central sensitisation by testing PPTs
in OA patients and age- and sex-matched controls18. PPTs at the
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in OA subjects compared to controls (P < 0.001). PPTs were also
found to be signiﬁcantly correlated to pain visual analogue scale
(VAS) scores.
Treatment
The views of patients and physicians differ on the importance of
disability due to disease and on how to manage it. For this reason,
Benhamou et al. developed a novel questionnaire based on in-depth
patient interviews and thenwith the views of physicians in order to
assess patient expectation of OA at an earlier disease stage19.
Eighteen questions were grouped by three main factors: education;
technical and human support; and physician empathy. This ques-
tionnaire has improved construct validity due the inclusion of both
patient and expert opinion during its development. Marra et al.
tested a multidisciplinary intervention for knee OA at the com-
munity pharmacy level against usual care (educational
pamphlet)20. The patients with the intervention had signiﬁcant
improvements in WOMAC scores compared to usual care 3 and 6
months later (P < 0.01).
Pharmacologic therapies
New avenues for disease modifying OA drugs have been
explored during the past year, in particular a randomised control
trial of strontium ranelate in a 3 year large-scale trial by Reginster
et al.21. They compared 1 and 2 g dose treatment to a control group
and compared structural progression and reduction of pain as a
secondary outcome. Both doses were signiﬁcantly associated with
reduction in joint space width (1 g, P < 0.001; 2 g, P ¼ 0.018), while
the 2 g dose was signiﬁcantly associated with a lower WOMAC
score (P ¼ 0.045). Klop et al. compared the risk of patients using
cyclooxygenase (COX)-2-selective non-steroidal anti-inﬂammatory
drugs (NSAIDs) having a joint replacement to those using non-
selective NSAIDs22. A large-scale population-based caseecontrol
study (26,202 cases) found that non-selective NSAIDs were not
associated with future joint replacement (hip: OR 0.89 [95% CI
0.65e1.22], knee: OR 0.74 [95% CI 0.49e1.11]) compared to patients
on COX-2-selected NSAIDs.
Rehab and physiotherapy
Hurley et al. conducted an randomized controlled trial (RCT) to
test the long-term beneﬁts of a specialised rehabilitation program
(ESCAPE (enabling self-management and coping with arthritic knee
pain through exercise)-knee pain) combining patient education,
self-management strategies and exercise against usual care23. They
found that the intervention had large initial improvements in
WOMAC function (mean 5.5 [95% CI 7.8, 3.2]) which reduced
over time, but remained signiﬁcantly better than the control group
up to 30 months after the intervention (mean 2.8 [95% CI 5.3,
0.2]).
Total joint replacement e predictors of outcomes
Culliford et al. computed the lifetime risk of lower limb
arthroplasty in the UK for a 50-year-oldman andwomen24. The risk
for THR (total hip replacement) was 11.6% for women and 7.1% for
men. For TKR (total knee replacement) the risk was 10.8% for
women and 8.1% for men. Jones et al. followed 520 patients with a
primary arthroplasty and demonstrated that severe obesity
(BMI > 35) was present in 19% of patients and was associated with
worse pain and functional recovery at 6 months but not at 3 years
following surgery25. Judge et al. explored the predictors of theoutcome of TKR at 6 months in 1991 patients. Patients with worse
pre-operative symptoms, with worse anxiety/depression, from
poorer areas and with an indication of OA compared to rheumatoid
arthritis had a worse outcome, however BMI was not a clinically
important predictor of outcome26.
Total joint replacement e failure and mortality
Gooch et al. performed a large RCT comparing 1,066 patients for
hip and knee replacement surgery who went through a new care
pathway (NCP) with 504 patients who received the standard of care
(SOC)27. Patients using the NCP had signiﬁcantly higher WOMAC
scores and quality of life (QOL) after surgery at both 3 and 12
months compared to patients in normal care, Although statistically
signiﬁcant, these changes were small at 2.56 for WOMAC and 1.88
for short form health survey (SF)-36 physical function (non-sig-
niﬁcant) and 3.01 for SF-36 bodily pain, but do demonstrate the
impotence of the delivery of care in determining the outcome of
medical interventions. Smith et al. used the UK National joint reg-
istry from 2003 to 2011 to assess the revision rates of metal on
metal (MoM) hip resurfacings compared to ceramic on ceramic and
metal on polyethylene stemmed prostheses28. In women, hip
resurfacing had worse implant survival than THR irrespective of
head size. In men, smaller head sizes were associated with
increased 5-year revision rates and therefore small head sizes were
not recommended. In women, all MoM resurfacings had a sub-
stantially increased revision risk (up to 8.3%) and were therefore
not recommended. McMinn et al. studied 275,000 patients using
UK National joint registry and compared the outcome of cemented
and non-cemented total hip replacements29. Patients who received
a cemented prosthesis had a higher mortality rate but a reduced
revision risk compared to uncemented prostheses.
Conclusion
The conclusions from these studies emphasise the need for
better disease phenotyping of obesity-related risk factors by dis-
tinguishing metabolic syndrome from the biomechanical effects of
obesity, as well as the improved characterisation of patients with
centralised as opposed to localised pain. Better phenotyping would
improve patient selection for genetic studies, as well as for inter-
vention strategies including determining those who would most
beneﬁt from disease modifying osteoarthritis drugs. The delivery of
personalised care is another strong trend, highlighting the impor-
tance of predictive modelling to establish which patients would
beneﬁt more from surgery and lessen the likely-hood of poor
outcomes after surgery.
This review of clinical OA over the past year found research
relating to obesity and metabolic syndrome, non-localised pain
modalities, novel disease modifying drugs and risk factors for
better outcomes after joint replacement. It has highlighted a
continuing, andwelcome, move towards predicting outcomes of OA
with the eventual aim of delivering personalised medicine to
patients.
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